A new Trinity study highlights that fitness may be a more important clinical endpoint for improvement in patients with fatty liver disease during exercise trials, rather than weight loss. The findings have been published in the medical journal Alimentary Pharmacology and Therapeutics. Metabolic associated fatty liver disease (MAFLD) is a condition characterised by a build-up of...
